The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post-ASCT consolidation with EPD or ERD in patients with high-risk multiple myeloma.
 
Eli Zolotov
No Relationships to Disclose
 
Maciej Kabat
No Relationships to Disclose
 
Harsh Parmar
Consulting or Advisory Role - Cellectar; Cellectar
 
Palka Anand
No Relationships to Disclose
 
Josh Zenreich
No Relationships to Disclose
 
Adolfo Aleman
No Relationships to Disclose
 
Pooja Phull
No Relationships to Disclose
 
David H. Vesole
Stock and Other Ownership Interests - Abbvie; Amgen; Biogen; Bristol-Myers Squibb; Gilead Sciences; Johnson & Johnson; Lilly; Merck; Novartis
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Sanofi; Takeda
 
David Samuel DiCapua Siegel
Stock and Other Ownership Interests - COTA
Honoraria - BMS; Envision Pharma Group; Menarini Silicon Biosystems; Merck; Pfizer; Sebia
Consulting or Advisory Role - BMS; Envision Pharma Group; Menarini Silicon Biosystems; Merck; Pfizer; Sebia
 
Noa Biran
Honoraria - Abbvie; Bristol-Myers Squibb; Janssen Oncology; Karyopharm Therapeutics; Pfizer
Consulting or Advisory Role - Pfizer; Sanofi/Aventis
Speakers' Bureau - Bristol-Myers Squibb; Janssen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Karyopharm Therapeutics (Inst)